Trial NCT01240642

View at ClinicalTrials.gov 
Org. Study IDs: CASA404A2112
Secondary IDs: 2009-011142-26

Last trial update was posted on 2020-12-09

MeSH Interventions

Vadimezan

MeSH Conditions

Neoplasm Metastasis Neoplasms Neoplasms, Second Primary Renal Insufficiency

Other Conditions

Metastatic Cancer With Impaired Renal Function Metastatic Cancer With Normal Renal Function

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID